Skip to content

Clinical trials

Completed Phase 1/2 Colonic Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Colonic Neoplasms Phase: Phase 1/2 Status: Completed Clear all

70 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20007
20014
20022
20043
20053
20062
20073
20083
20092
20103
20111
20127
20133
20151
20163
20172
20185
20191
20202
20211
20222
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed70

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)6
Memorial Sloan Kettering Cancer Center4
Amgen2
Gilead Sciences2
Northwestern University2
Swiss Cancer Institute2
The University of Texas Health Science Center at San Antonio2
Abramson Cancer Center at Penn Medicine1
AlphaVax, Inc.1
Arya, Vijaypal, M.D., P.C.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Colonic Neoplasms70
Colorectal Neoplasms45
Rectal Neoplasms39
Pancreatic Neoplasms18
Breast Neoplasms14
Head and Neck Neoplasms11
Neoplasms10
Neoplasm Metastasis9
Lung Neoplasms8
Ovarian Neoplasms8

Trials

Showing 1 to 25 of 70. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.